Loading...

Soiken Holdings Inc.

2385.TJPX
Healthcare
Biotechnology
¥166.00
¥1.00(0.61%)

Soiken Holdings Inc. (2385.T) Company Profile & Overview

Explore Soiken Holdings Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Soiken Holdings Inc. (2385.T) Company Profile & Overview

Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for physician-led pharmaceutical clinical research, health checkups, and specific health guidance; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.

SectorHealthcare
IndustryBiotechnology
CEOKentaro Ishigami

Contact Information

81 6 6871 8888
Senri Life Science Center, Toyonaka, 560-0082

Company Facts

90 Employees
IPO DateDec 18, 2003
CountryJP
Actively Trading

Frequently Asked Questions

;